What is it about?
Interleukin-17A signaling plays important role in autoimmune diseases and host-defense. The balance between good and bad effects depend upon the 14-3-3zeta presence in the cells. 14-3-3zeta interacts with TRAF5 and regulates its activity. The 14-3-3zeta-TRAF5 axis is a new regulation that helps us understand how IL-17A signaling works.
Featured Image
Photo by Pablo García Saldaña on Unsplash
Why is it important?
Instead of global inhibition, this new regulation will help design better IL-17A based-therapeutics.
Perspectives
We finding this regulation is very exciting. Not only it showed us how little we know about IL-17A signaling, but how IL-17A has diverse effects. We believe that this discovery will pave the way for better therapies targeting IL-17A signaling, and minimize the side-effects.
Ritu Chakravarti
University of Toledo College of Medicine and Life Sciences
Read the Original
This page is a summary of: 14-3-3ζ–TRAF5 axis governs interleukin-17A signaling, Proceedings of the National Academy of Sciences, September 2020, Proceedings of the National Academy of Sciences,
DOI: 10.1073/pnas.2008214117.
You can read the full text:
Resources
Contributors
The following have contributed to this page
